Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-suscep ...

all-oral treatments for rifampin-resistant tuberculosis. We conducted a phase 3, multinational, open-label, randomized, controlled noninferiority trial to compare standard therapy for treatment of ...

Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

HealthDay News — In a clinical practice guideline issued by the American Thoracic Society and published in the January issue of the American Journal of Respiratory and Critical Care Medicine, updated ...

More than 60 people were being treated in the Kansas City area as of Friday, according to the state health department.

Emerging drug-resistant strains are posing significant challenges to the global fight against tuberculosis (TB) and it is a critical task to detect treatment failure as early as possible.

The treatment is very costly for both families and health services. In September 2024, the World Health Organization issued new guidelines for MDR-TB preventive therapy. The guidelines were based ...

Home > Pressemitteilung: Molecular Bacterial Load Assay: New ...